Details of Drug

Drug General Information (ID: D1430)
Drug Name	Rosuvastatin
Drug Type	Small molecule
Drug Synonymous	Astende; Cirantan; Cresadex; Creston; Crestor; Provisacor; Razel; Rosedex; Rosimol; Rosumed; Rosustatin; Rosuvas; Rosuvast; Rosvel; Rovartal; Simestat; Sinlip; Vivacor; Rosuvastatin [INN]; Rosuvastatin calcium; Rosuvastatin calcium [USAN]; Rosuvastatin hemicalcium; S 4522; ZD 4522; ZD4522; AZD-4522; Creston (TN);Crestor (TN); Pyrimidine Compound, 26; Rosuvastatin (INN); S-4522; ZD 4522, calcium salt; ZD-4522; Rosuvastatin calcium (JAN/USAN); Bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino] pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhelpt-6-enoic acid] calcium salt; Calcium (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate; (3R,5S,6E)-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-(propan-2-yl)pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (3R,5S,6E)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; (E,3R,5R)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (S-((R,S-(E)))-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl) amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); (S-(R,S-(E)))-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid, calcium salt (2:1); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, (3R,5S,6E); 6-Heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, calcium salt (2:1), (3R,5S,6E) Click to Show/Hide
Disease Class	5C80: Hyper-lipoproteinaemia; MA14: Blood/blood-forming organ sympton
Therapeutic Class	Statins/Antihyperlipidemic Agents
Structure
Structure	3D Structure		2D Structure
Formula	C22H28FN3O6S
InChI	1S/C22H28FN3O6S/c1-13(2)20-18(10-9-16(27)11-17(28)12-19(29)30)21(14-5-7-15(23)8-6-14)25-22(24-20)26(3)33(4,31)32/h5-10,13,16-17,27-28H,11-12H2,1-4H3,(H,29,30)/b10-9+/t16-,17-/m1/s1
InChIKey	BPRHUIZQVSMCRT-VEUZHWNKSA-N
Canonical SMILES	CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
External Link
	Pubchem ID	446157
	CAS Number	287714-41-4
	CHEBI ID	38545
	TTD ID	D0JE2E
	INTEDE ID	DR1445
	VARIDT ID	DR00223

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM001 Affected gastrointestinal absorption AM002 Affected cellular transport AM004 Affected intra/extra-hepatic metabolism AM006 Pharmacodynamic additive effects BM001 Altered gastrointestinal dynamics BM003 Complex formation BM005 Altered gastric pH BM010 Transporter inhibition BM011 Transporter induction BM017 CYP450 enzyme inhibition BM022 CYP450 enzyme induction BM023 UGT induction BM025 Decreased metabolism (Unspecific) BM050 Increased risk of bleeding BM055 Increased risk of hepatotoxicity BM074 Increased risk of peripheral neuropathy BM109 Increased risk of other adverse reactions (Unspecific)
Relation Graph

Full list of drugs interacting with Rosuvastatin
Affected gastrointestinal absorption
	Altered gastrointestinal dynamics					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0597		Erythromycin	C37H67NO13	12560	Minor		Inter Info	[6]
	Complex formation					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1369		Quinapril	C25H30N2O5	54892	Moderate		Inter Info	[2], [78]
	Altered gastric pH					Drug Num: 7
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0049		Aluminum hydroxide	AlH3O3	10176082	Moderate		Inter Info	[6]
D0236		Calcium carbonate	CCaO3	10112	Moderate		Inter Info	[6]
D0967		Magaldrate	AlHMgO5S+2	3086011	Moderate		Inter Info	[6]
D0968		Magnesium carbonate	CMgO3	11029	Moderate		Inter Info	[6]
D0973		Magnesium hydroxide	H2MgO2	14791	Moderate		Inter Info	[6]
D0974		Magnesium oxide	MgO	14792	Moderate		Inter Info	[6]
D1483		Sodium citrate	C6H5Na3O7	6224	Moderate		Inter Info	[6]
Affected cellular transport
	Transporter inhibition					Drug Num: 34
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0080		Amprenavir	C25H35N3O6S	65016	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16]
D0116		Atazanavir	C38H52N6O7	148192	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16]
D0402		Cyclosporine	C62H111N11O12	5284373	Major		Inter Info	[20], [6], [21]
D1119		Nelfinavir	C32H45N3O4S	64143	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16]
D1415		Ritonavir	C37H48N6O5S2	392622	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16]
D0425		Darolutamide	C19H19ClN6O2	67171867	Major		Inter Info	[2], [6], [34]
D0426		Darunavir	C27H37N3O7S	213039	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16]
D0568		Enasidenib	C19H17F6N7O	89683805	Major		Inter Info	[1], [35]
D0715		Gemfibrozil	C15H22O3	3463	Major		Inter Info	[6], [38]
D0726		Glecaprevir	C38H46F4N6O9S	66828839	Major		Inter Info	[39]
D0739		Grazoprevir	C38H50N6O9S	44603531	Major		Inter Info	[1], [2], [40]
D0948		Lopinavir	C37H48N4O5	92727	Major		Inter Info	[4], [5], [12]
D1471		Simeprevir	C38H47N5O7S2	24873435	Major		Inter Info	[43]
D1686		Velpatasvir	C49H54N8O8	67683363	Major		Inter Info	[44]
D1710		Voxilaprevir	C40H52F4N6O9S	89921642	Major		Inter Info	[44], [45]
D0155		Bempedoic acid	C19H36O5	10472693	Moderate		Inter Info	[81], [82]
D0204		Brigatinib	C29H39ClN7O2P	68165256	Moderate		Inter Info	[2], [85], [86]
D0251		Capmatinib	C23H17FN6O	25145656	Moderate		Inter Info	[87]
D0302		Ceritinib	C28H36ClN5O3S	57379345	Moderate		Inter Info	[2], [88]
D0375		Cobicistat	C40H53N7O5S2	25151504	Moderate		Inter Info	[2], [8], [89]
D0406		Dabrafenib	C23H20F3N5O2S2	44462760	Moderate		Inter Info	[1], [2], [90]
D0408		Daclatasvir	C40H50N8O6	25154714	Moderate		Inter Info	[2], [91], [92]
D0558		Elexacaftor	C26H34F3N7O4S	134587348	Moderate		Inter Info	[93], [94], [95]
D0569		Encorafenib	C22H27ClFN7O4S	50922675	Moderate		Inter Info	[2], [96]
D0700		Fostemsavir	C25H26N7O8P	11319217	Moderate		Inter Info	[98]
D0725		Glasdegib	C21H22N6O	25166913	Moderate		Inter Info	[2], [99]
D0897		Lasmiditan	C19H18F3N3O2	11610526	Moderate		Inter Info	[101]
D0906		Letermovir	C29H28F4N4O4	45138674	Moderate		Inter Info	[102]
D1062		Midostaurin	C35H30N4O4	9829523	Moderate		Inter Info	[2]
D1167		Olaparib	C24H23FN4O3	23725625	Moderate		Inter Info	[1], [2]
D1423		Rolapitant	C25H26F6N2O2	10311306	Moderate		Inter Info	[108]
D1436		Sacubitril	C24H29NO5	9811834	Moderate		Inter Info	[109], [2], [92]
D1528		Tafamidis	C14H7Cl2NO3	11001318	Moderate		Inter Info	[2], [110], [111]
D1539		Tedizolid	C17H15FN6O3	11234049	Moderate		Inter Info	[2], [112]
	Transporter induction					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0095		Apalutamide	C21H15F4N5O2S	24872560	Moderate		Inter Info	[2], [80]
Affected intra/extra-hepatic metabolism
	CYP450 enzyme induction					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0044		Alpelisib	C19H22F3N5O2S	56649450	Moderate		Inter Info	[79]
D0953		Lorlatinib	C21H19FN6O2	71731823	Moderate		Inter Info	[1], [2], [103]
	UGT induction					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0601		Eslicarbazepine	C15H14N2O2	9881504	Moderate		Inter Info	[2], [97]
	Decreased metabolism (Unspecific)					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0799		Indinavir	C36H47N5O4	5362440	Major		Inter Info	[2], [22], [23]
Pharmacodynamic additive effects
	Increased risk of bleeding					Drug Num: 3
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0481		Dicoumarol	C19H12O6	54676038	Moderate		Inter Info	[65], [66], [6]
D0087		Anisindione	C16H12O3	2197	Moderate		Inter Info	[65], [66], [6]
D1711		Warfarin	C19H16O4	54678486	Moderate		Inter Info	[65], [66], [6]
	Increased risk of hepatotoxicity					Drug Num: 20
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0900		Leflunomide	C12H9F3N2O2	3899	Major		Inter Info	[1], [2], [24], [25]
D0944		Lomitapide	C39H37F6N3O2	9853053	Major		Inter Info	[41]
D1073		Mipomersen	C230H324N67O122P19S19	118984467	Major		Inter Info	[42]
D1556		Teriflunomide	C12H9F3N2O2	54684141	Major		Inter Info	[1], [2], [24], [25]
D0114		Asparaginase Escherichia coli	NA	NA	Moderate		Inter Info	[49], [50], [51], [1], [2], [52], [53], [54], [55], [56], [57], [58], [59]
D0357		Clofarabine	C10H11ClFN5O3	119182	Moderate		Inter Info	[63]
D0554		Efavirenz	C14H9ClF3NO2	64139	Moderate		Inter Info	[67], [68]
D0584		Epirubicin	C27H29NO11	41867	Moderate		Inter Info	[1], [2], [69]
D0617		Ethanol	C2H6O	702	Moderate		Inter Info	[6], [70], [71]
D0826		Interferon beta-1a	NA	NA	Moderate		Inter Info	[72], [73], [74], [75]
D0827		Interferon beta-1b	NA	NA	Moderate		Inter Info	[72], [73], [74], [75]
D1025		Methotrexate	C20H22N8O5	126941	Moderate		Inter Info	[2], [76]
D1106		Naltrexone	C20H23NO4	5360515	Moderate		Inter Info	[77]
D1234		Pegaspargase	C14H19NO	436058	Moderate		Inter Info	[49], [50], [51], [1], [2], [52], [53], [54], [55], [56], [57], [58], [59]
D0199		Brentuximab vedotin	NA	NA	Moderate		Inter Info	[83], [84]
D0789		Idelalisib	C22H18FN7O	11625818	Moderate		Inter Info	[100]
D1232		Pazopanib	C21H23N7O2S	10113978	Moderate		Inter Info	[1], [104], [92]
D1389		Remdesivir	C27H35N6O8P	121304016	Moderate		Inter Info	[1], [2], [105], [106], [107]
D1615		Trabectedin	C39H43N3O11S	108150	Moderate		Inter Info	[2], [115]
D1589		Tioguanine	C5H5N5S	2723601	Moderate		Inter Info	[117], [118]
	Increased risk of peripheral neuropathy					Drug Num: 69
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0023		Adalimumab	NA	NA	Moderate		Inter Info	[46], [47], [48]
D0120		Atorvastatin	C33H35FN2O5	60823	Moderate		Inter Info	[46], [47], [48]
D0126		Auranofin	C20H34AuO9PS	24199313	Moderate		Inter Info	[46], [47], [48]
D0193		Bortezomib	C19H25BN4O4	387447	Moderate		Inter Info	[60], [61], [62]
D0260		Carboplatin	C6H12N2O4Pt	426756	Moderate		Inter Info	[46], [47], [48]
D0303		Cerivastatin	C26H34FNO5	446156	Moderate		Inter Info	[46], [47], [48]
D0313		Chloramphenicol	C11H12Cl2N2O5	5959	Moderate		Inter Info	[46], [47], [48]
D0320		Chloroquine	C18H26ClN3	2719	Moderate		Inter Info	[46], [47], [48]
D0344		Cisplatin	Cl2H6N2Pt	5702198	Moderate		Inter Info	[46], [47], [48]
D0419		Dapsone	C12H12N2O2S	2955	Moderate		Inter Info	[46], [47], [48]
D0483		Didanosine	C10H12N4O3	135398739	Moderate		Inter Info	[46], [47], [48]
D0509		Disulfiram	C10H20N2S4	3117	Moderate		Inter Info	[46], [47], [48]
D0614		Etanercept	NA	NA	Moderate		Inter Info	[46], [47], [48]
D0616		Ethambutol	C10H24N2O2	14052	Moderate		Inter Info	[46], [47], [48]
D1731		Ethionamide	C8H10N2S	2761171	Moderate		Inter Info	[46], [47], [48]
D0627		Etoposide	C29H32O13	36462	Moderate		Inter Info	[46], [47], [48]
D0669		Fludarabine	C10H12FN5O4	657237	Moderate		Inter Info	[46], [47], [48]
D0686		Fluvastatin	C24H26FNO4	446155	Moderate		Inter Info	[46], [47], [48]
D0821		Interferon alfa-2a, Recombinant	NA	NA	Moderate		Inter Info	[46], [47], [48]
D0822		Interferon alfa-2b	C16H17Cl3I2N3NaO5S	71306834	Moderate		Inter Info	[46], [47], [48]
D0824		Interferon alfa-n1	NA	NA	Moderate		Inter Info	[46], [47], [48]
D0823		Interferon alfacon-1	NA	NA	Moderate		Inter Info	[46], [47], [48]
D0858		Isoniazid	C6H7N3O	3767	Moderate		Inter Info	[46], [47], [48]
D0933		Linezolid	C16H20FN3O4	441401	Moderate		Inter Info	[46], [47], [48]
D0956		Lovastatin	C24H36O5	53232	Moderate		Inter Info	[46], [47], [48]
D1051		Metronidazole	C6H9N3O3	4173	Moderate		Inter Info	[46], [47], [48]
D1193		Oxaliplatin	C8H14N2O4Pt	9887053	Moderate		Inter Info	[46], [47], [48]
D1237		Peginterferon alfa-2a	NA	NA	Moderate		Inter Info	[46], [47], [48]
D1238		Peginterferon alfa-2b	NA	NA	Moderate		Inter Info	[46], [47], [48]
D1329		Pravastatin	C23H36O7	54687	Moderate		Inter Info	[46], [47], [48]
D0066		Amiodarone	C25H29I2NO3	2157	Moderate		Inter Info	[46], [47], [48]
D0127		Aurothioglucose	C6H11AuO5S	454937	Moderate		Inter Info	[46], [47], [48]
D0162		Benznidazole	C12H12N4O3	31593	Moderate		Inter Info	[46], [47], [48]
D0227		Cabazitaxel	C45H57NO14	9854073	Moderate		Inter Info	[46], [47], [48]
D0261		Carfilzomib	C40H57N5O7	11556711	Moderate		Inter Info	[46], [47], [48]
D0304		Certolizumab pegol	NA	NA	Moderate		Inter Info	[46], [47], [48]
D0393		Crizotinib	C21H22Cl2FN5O	11626560	Moderate		Inter Info	[46], [47], [48]
D0496		Diiodohydroxyquinoline	C9H5I2NO	3728	Moderate		Inter Info	[46], [47], [48]
D0511		Docetaxel	C43H53NO14	148124	Moderate		Inter Info	[46], [47], [48]
D0560		Elotuzumab	NA	NA	Moderate		Inter Info	[46], [47], [48]
D0571		Enfortumab vedotin	NA	NA	Moderate		Inter Info	[46], [47], [48]
D0594		Eribulin	C40H59NO11	11354606	Moderate		Inter Info	[46], [47], [48]
D0736		Golimumab	NA	NA	Moderate		Inter Info	[46], [47], [48]
D0770		Hydralazine	C8H8N4	3637	Moderate		Inter Info	[46], [47], [48]
D0779		Hydroxychloroquine	C18H26ClN3O	3652	Moderate		Inter Info	[46], [47], [48]
D0841		Ipilimumab	NA	NA	Moderate		Inter Info	[46], [47], [48]
D0873		Ixabepilone	C27H42N2O5S	6445540	Moderate		Inter Info	[46], [47], [48]
D0874		Ixazomib	C14H19BCl2N2O4	25183872	Moderate		Inter Info	[46], [47], [48]
D0918		Levodopa	C9H11NO4	6047	Moderate		Inter Info	[46], [47], [48]
D1113		Naxitamab	NA	NA	Moderate		Inter Info	[46], [47], [48]
D1118		Nelarabine	C11H15N5O5	3011155	Moderate		Inter Info	[46], [47], [48]
D1213		Paclitaxel (protein-bound)	C47H51NO14	36314	Moderate		Inter Info	[46], [47], [48]
D1301		Pitavastatin	C25H24FNO4	5282452	Moderate		Inter Info	[46], [47], [48]
D1306		Polatuzumab vedotin	NA	NA	Moderate		Inter Info	[46], [47], [48]
D1313		Ponatinib	C29H27F3N6O	24826799	Moderate		Inter Info	[46], [47], [48]
D1452		Secnidazole	C7H11N3O3	71815	Moderate		Inter Info	[46], [47], [48]
D1479		Sodium aurothiomalate	C4H3AuNa2O4S	22318	Moderate		Inter Info	[46], [47], [48]
D1599		Tocilizumab	NA	NA	Moderate		Inter Info	[46], [47], [48]
D1623		Trastuzumab emtansine	NA	NA	Moderate		Inter Info	[46], [47], [48]
D1473		Simvastatin	C25H38O5	54454	Moderate		Inter Info	[46], [47], [48]
D1504		Stavudine	C10H12N2O4	18283	Moderate		Inter Info	[46], [47], [48]
D1551		Teniposide	C32H32O13S	452548	Moderate		Inter Info	[46], [47], [48]
D1569		Thalidomide	C13H10N2O4	5426	Moderate		Inter Info	[60], [1], [2], [116]
D1587		Tinidazole	C8H13N3O4S	5479	Moderate		Inter Info	[46], [47], [48]
D1697		Vinblastine	C46H58N4O9	13342	Moderate		Inter Info	[46], [47], [48]
D1698		Vincristine	C46H56N4O10	5978	Moderate		Inter Info	[46], [47], [48]
D1699		Vincristine (liposome)	C46H56N4O10	5978	Moderate		Inter Info	[46], [47], [48]
D1700		Vinorelbine	C45H54N4O8	5311497	Moderate		Inter Info	[46], [47], [48]
D1715		Zalcitabine	C9H13N3O3	24066	Moderate		Inter Info	[60], [119]
	Increased risk of other adverse reactions (Unspecific)					Drug Num: 9
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0360		Clofibrate	C12H15ClO3	2796	Major		Inter Info	[17], [18], [19]
D0642		Fenofibrate	C20H21ClO4	3339	Major		Inter Info	[17], [18], [19]
D0902		Lenalidomide	C13H13N3O3	216326	Major		Inter Info	[2], [26], [27]
D1129		Niacin	C6H5NO2	938	Major		Inter Info	[28], [29], [30]
D0380		Colchicine	C22H25NO6	6167	Major		Inter Info	[31], [32], [33]
D0643		Fenofibric acid	C17H15ClO4	64929	Major		Inter Info	[36], [37]
D0421		Daptomycin	C72H101N17O26	16134395	Moderate		Inter Info	[28], [30], [64]
D1543		Telbivudine	C10H14N2O5	159269	Moderate		Inter Info	[113], [114]
D1720		Zidovudine	C10H13N5O4	35370	Moderate		Inter Info	[113], [114]

References
1	Cerner Multum, Inc. "Australian Product Information.".
2	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
3	Hirano M, Maeda K, Shitara Y, Sugiyama Y "Drug-drug interaction between pitavastatin and various drugs via OATP1B1." Drug Metab Dispos 34 (2006): 1229-36. [PMID: 16595711]
4	Neuvonen PJ, Niemi M, Backman JT "Drug interactions with lipid-lowering drugs: Mechanisms and clinical relevance." Clin Pharmacol Ther 80 (2006): 565-81. [PMID: 17178259]
5	Product Information. Aptivus (tipranavir). Boehringer-Ingelheim, Ridgefield, CT.
6	Product Information. Crestor (rosuvastatin). AstraZeneca Pharma Inc, Mississauga, ON.
7	Product Information. Crixivan (indinavir). Merck & Co, Inc, West Point, PA.
8	Product Information. Evotaz (atazanavir-cobicistat). Bristol-Myers Squibb, Princeton, NJ.
9	Product Information. Invirase (saquinavir). Roche Laboratories, Nutley, NJ.
10	Product Information. Kaletra (lopinavir-ritonavir) Abbott Pharmaceutical, Abbott Park, IL.
11	Product Information. Lexiva (fosamprenavir). GlaxoSmithKline, Research Triangle Park, NC.
12	Product Information. Norvir (ritonavir). Abbott Pharmaceutical, Abbott Park, IL.
13	Product Information. Prezista (darunavir). Ortho Biotech Inc, Bridgewater, NJ.
14	Product Information. Reyataz (atazanavir). Bristol-Myers Squibb, Princeton, NJ.
15	Product Information. Viekira Pak (dasabuvir/ombitasvir/paritaprevir/ritonavir). AbbVie US LLC, North Chicago, IL.
16	US Food and Drug Administration "FACT SHEET FOR HEALTHCARE PROVIDERS EMERGENCY USE AUTHORIZATION FOR PAXLOVID.".
17	Backman JT, Kyrklund C, Neuvonen M, Neuvonen PJ "Gemfibrozil greatly increases plasma concentrations of cerivastatin." Clin Pharmacol Ther 72 (2002): 685-91.[PMID: 12496749]
18	Duell PB, Connor WE, Illingworth DR "Rhabdomyolysis after taking atorvastatin with gemfibrozil." Am J Cardiol 81 (1998): 368-9.[PMID: 9468088]
19	Mastroianni CM, dEttorre G, Forcina G, Lichtner M, Corpolongo A, Coletta S, Vullo V "Rhabdomyolysis after cerivastatin-gemfibrozil therapy in an HIV-infected patient with protease inhibitor-related hyperlipidemia." AIDS 15 (2001): 820-1.[PMID: 11371708]
20	Holtzman CW, Wiggins BS, Spinler SA "Role of P-glycoprotein in statin drug interactions." Pharmacotherapy 26 (2006): 1601-7. [PMID: 17064205]
21	Simonson SG, Raza A, Martin PD, et al. "Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporine." Clin Pharmacol Ther 76 (2004): 167-77. [PMID: 15289793]
22	Product Information. Crixivan (indinavir). Merck &amp Co, Inc, West Point, PA.
23	Shelton MJ, Wynn HE, Newitt RG, DiFrancesco R "Effects of grapefruit juice on pharmacokinetic exposure to indinavir in HIV-positive subjects." J Clin Pharmacol 41 (2001): 435-42. [PMID: 11304900]
24	EMEA "EMEA public statement on leflunomide (ARAVA) - severe and serious hepatic reactions.".
25	Product Information. Arava (leflunomide). Hoechst Marion-Roussel Inc, Kansas City, MO.
26	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports."
27	EMA. European Medicines Agency. Committee for Medicinal Products for Human Use (CHMP) "Revlimid."
28	Product Information. Vytorin (ezetimibe-simvastatin). Merck &amp Company Inc, West Point, PA.
29	Product Information. Mevacor (lovastatin). Merck &amp Co, Inc, West Point, PA.
30	Product Information. Zocor (simvastatin). Merck &amp Co, Inc, West Point, PA.
31	Colchicine: serious interactions. Prescrire Int 17 (2008): 151-3. [PMID: 19492485]
32	Wilbur K, Makowsky M "Colchicine myotoxicity: case reports and literature review." Pharmacotherapy 24 (2004): 1784-92. [PMID: 15585444]
33	Montiel V, Huberlant V, Vincent MF, Bonbled F, Hantson P "Multiple organ failure after an overdose of less than 0.4 mg/kg of colchicine: role of coingestants and drugs during intensive care management." Clin Toxicol (Phila) 48 (2010): 845-8.[PMID: 20969505]
34	Product Information. Nubeqa (darolutamide). Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ.
35	Product Information. Idhifa (enasidenib). Celgene Corporation, Summit, NJ.
36	Product Information. Trilipix (fenofibric acid). Abbott Pharmaceutical, Abbott Park, IL.
37	Unal A, Torun E, Sipahioglu MH, et al. "Fenofibrate-induced acute renal failure due to massive rhabdomyolysis after coadministration of statin in two patients." Intern Med 47 (2008): 1017-9.[PMID: 18520113]
38	Schneck DW, Birmingham BK, Zalikowski JA, et al. "The effect of gemfibrozil on the pharmacokinetics of rosuvastatin." Clin Pharmacol Ther 75 (2004): 455-63. [PMID: 15116058]
39	Product Information. Mavyret (glecaprevir-pibrentasvir). Abbott Pharmaceutical, Abbott Park, IL.
40	Product Information. Zepatier (elbasvir-grazoprevir). Merck &amp Company Inc, Whitehouse Station, NJ.
41	Product Information. Juxtapid (lomitapide). Aegerion Pharmaceuticals Inc, Cambridge, MA.
42	Product Information. Kynamro (mipomersen). Genzyme Corporation, Cambridge, MA.
43	Product Information. Olysio (simeprevir). Janssen Pharmaceuticals, Titusville, NJ.
44	Product Information. Epclusa (sofosbuvir-velpatasvir). Gilead Sciences, Foster City, CA.
45	Product Information. Vosevi (sofosbuvir/velpatasvir/voxilaprevir). Gilead Sciences, Foster City, CA.
46	Carrion C, Espinosa E, Herrero A, Garcia B "Possible vincristine-isoniazid interaction." Ann Pharmacother 29 (1995): 201. [PMID: 7756727]
47	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
48	Pharmaceutical Society of Australia "APPGuide online. Australian prescription products guide online."
49	Al-Nawakil C, Willems L, Mauprivez C, et.al "Successful treatment of l-asparaginase-induced severe acute hepatotoxicity using mitochondrial cofactors." Leuk Lymphoma 55 (2014): 1670-4. [PMID: 24090500]
50	Bodmer M, Sulz M, Stadlmann S, Droll A, Terracciano L, Krahenbuhl S "Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-asparaginase." Digestion 74 (2006): epub. [PMID: 16988508]
51	Cerner Multum, Inc "ANVISA Bulario Eletrnico.".
52	Christ TN, Stock W, Knoebel RW "Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen." J Oncol Pharm Pract 24 (2018): 299-308. [PMID: 28355969]
53	Jenkins R, Perlin E "Severe hepatotoxicity from Escherichia coli L-asparaginase." J Natl Med Assoc 79 (1987): 775-9. [PMID: 3305969]
54	Lu G, Karur V, Herrington JD, Walker MG "Successful treatment of pegaspargase-induced acute hepatotoxicity with vitamin B complex and L-carnitine" Proc (Bayl Univ Med Cent) 29 (2016): 46-7. [PMID: 26722167]
55	Product Information. Asparlas (calaspargase pegol). Servier, Boston, MA.
56	Product Information. Elspar (asparaginase). Merck & Co, Inc, West Point, PA.
57	Product Information. Erwinaze (asparaginase Erwinia chrysanthemi). EUSA Pharma, Newtown, PA.
58	Product Information. Oncaspar (pegaspargase). Rhone-Poulenc Rorer, Collegeville, PA.
59	Burke PW, Aldoss I, Lunning MA, et.al "High-grade PEGylated asparaginase-related hepatotoxicity occurrence in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not necessarily predict recurrent hepatotoxicity in subsequent cycles." Blood 122 (2013): 2671. [PMID: 29407583]
60	Argov Z, Mastaglia FL "Drug-induced peripheral neuropathies." Br Med J 1 (1979): 663-6. [PMID: 219931]
61	Cavaletti G, Jakubowiak AJ "Peripheral neuropathy during bortezomib treatment of multiple myeloma: a review of recent studies." Leuk Lymphoma 51 (2010): 1178-87. [PMID: 20497001]
62	Product Information. Velcade (bortezomib). Millennium Pharmaceuticals Inc, Cambridge, MA.
63	Product Information. Clolar (clofarabine). sanofi-aventis, Bridgewater, NJ.
64	Product Information. Cubicin (daptomycin). Cubist Pharmaceuticals Inc, Lexington, MA.
65	Bodiford AB, Kessler FO, Fermo JD, Ragucci KR "Elevated international normalized ratio with the consumption of grapefruit and use of warfarin." SAGE Open Med Case Rep 0 (2013): 1-3. [PMID: 27489634]
66	Guo LQ, Yamazoe Y "Inhibition of cytochrome P450 by furanocoumarins in grapefruit juice and herbal medicines." Acta Pharmacol Sin 25 (2004): 129-36. [PMID: 14769198]
67	Elsharkawy AM, Schwab U, McCarron B, et al. "Efavirenz induced acute liver failure requiring liver transplantation in a slow drug metaboliser." J Clin Virol 58 (2013): 331-3. [PMID: 23763943]
68	Product Information. Sustiva (efavirenz). DuPont Pharmaceuticals, Wilmington, DE.
69	Product Information. Ellence (epirubicin) Pharmacia and Upjohn, Kalamazoo, MI.
70	Product Information. Lipitor (atorvastatin). Parke-Davis, Morris Plains, NJ.
71	Product Information. Pravachol (pravastatin). Bristol-Myers Squibb, Princeton, NJ.
72	Product Information. Avonex (interferon beta-1a). Biogen, Cambridge, MA.
73	Product Information. Betaseron (interferon beta-1b). Berlex, Richmond, CA.
74	Product Information. Plegridy (peginterferon beta-1a). Biogen Idec Inc, Cambridge, MA.
75	Product Information. Rebif (interferon beta-1a). Serono Laboratories Inc, Norwell, MA.
76	Product Information. Methotrexate (methotrexate). Lederle Laboratories, Wayne, NJ.
77	Product Information. ReVia (naltrexone). DuPont Pharmaceuticals, Wilmington, DE.
78	Multum Information Services, Inc. Expert Review Panel.
79	Product Information. Piqray (alpelisib). Novartis Pharmaceuticals, East Hanover, NJ.
80	Product Information. Erleada (apalutamide). Janssen Biotech, Inc., Horsham, PA, PA.
81	Product Information. Nexletol (bempedoic acid). Esperion Therapeutics, Ann Arbor, MI.
82	Product Information. Nexlizet (bempedoic acid-ezetimibe). Esperion Therapeutics, Ann Arbor, MI.
83	Product Information. Accolate (zafirlukast). Zeneca Pharmaceuticals, Wilmington, DE.
84	Product Information. Adcetris (brentuximab vedotin). Seattle Genetics Inc, Bothell, WA.
85	Product Information. Alunbrig (brigatinib). Ariad Pharmaceuticals Inc, Cambridge, MA.
86	Product Information. Lonsurf (tipiracil-trifluridine). Taiho Oncology, Inc., Princeton, NJ.
87	Product Information. Tabrecta (capmatinib). Novartis Pharmaceuticals, East Hanover, NJ.
88	Product Information. Zykadia (ceritinib). Novartis Pharmaceuticals, East Hanover, NJ.
89	Product Information. Tybost (cobicistat). Gilead Sciences, Foster City, CA.
90	Product Information. Tafinlar (dabrafenib). GlaxoSmithKline, Research Triangle Park, NC.
91	Product Information. Daklinza (daclatasvir). Bristol-Myers Squibb, Princeton, NJ.
92	Richter WO, Jacob BG, Schwandt P "Interaction between fibre and lovastatin." Lancet 338 (1991): 706. [PMID: 1679514]
93	Product Information. Cozaar (losartan). Merck &amp Co, Inc, West Point, PA.
94	Product Information. Diovan (valsartan). Novartis Pharmaceuticals, East Hanover, NJ.
95	Product Information. Trikafta (elexacaftor/ivacaftor/tezacaftor). Vertex Pharmaceuticals, Cambridge, MA.
96	Product Information. Braftovi (encorafenib). Array BioPharma Inc., Boulder, CO.
97	Product Information. Aptiom (eslicarbazepine). Sunovion Pharmaceuticals Inc, Marlborough, MA.
98	Product Information. Rukobia (fostemsavir). ViiV Healthcare, Research Triangle Park, NC.
99	Product Information. Daurismo (glasdegib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
100	Product Information. Zydelig (idelalisib). Gilead Sciences, Foster City, CA.
101	Product Information. Reyvow (lasmiditan). Lilly, Eli and Company, Indianapolis, IN.
102	Product Information. Prevymis (letermovir). Merck & Company Inc, Whitehouse Station, NJ.
103	Product Information. Lorbrena (lorlatinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
104	Product Information. Votrient (pazopanib). GlaxoSmithKline, Research Triangle Park, NC.
105	European Medicines Agency "Summary on compassionate use. Remdesivir Gilead.".
106	Gilead Sciences, Inc "About Remdesivir.".
107	US Food and Drug Administration "Fact sheet for health care providers emergency use authorization (EUA) of remdesivir (GS-5734TM)".
108	Product Information. Varubi (rolapitant). Tesaro Inc., Waltham, MA.
109	Canadian Pharmacists Association.
110	Product Information. Vyndaqel (tafamidis). Pfizer U.S. Pharmaceuticals Group, New York, NY.
111	Agencia Espaola de Medicamentos y Productos Sanitarios Healthcare "Centro de informacion online de medicamentos de la AEMPS - CIMA."
112	Product Information. Sivextro (tedizolid). Cubist Pharmaceuticals Inc, Lexington, MA.
113	Product Information. Retrovir (zidovudine). Glaxo Wellcome, Research Triangle Park, NC.
114	Product Information. Tyzeka (telbivudine). IDEC Pharmaceuticals Corporation, San Diego, CA.
115	Product Information. Yondelis (trabectedin). Janssen Pharmaceuticals, Titusville, NJ.
116	Product Information. Thalomid (thalidomide). Celgene Corporation, Warren, NJ.
117	Product Information. Aubagio (teriflunomide). Genzyme Corporation, Cambridge, MA.
118	Product Information. Tabloid (thioguanine). Prasco Laboratories, Cincinnati, OH.
119	Product Information. Hivid (zalcitabine). Roche Laboratories, Nutley, NJ.

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence